RECENT FUNDING
  1. Recent Funding
  2. Companies
  3. Nuevocor

Nuevocor

Nuevocor is a IND-stage biotech focused on treating genetic cardiomyopathies by addressing their underlying mechanical defects

Latest funding

$45M Series B+ ·

Led by Angelini Ventures · Source: fundraisingfox.com

Total raised: $69M across 2 sourced rounds

All 2 rounds ↓
Website: nuevocor.com.
LinkedIn: nuevocor.
Category: Health and bio.
Sectors: Biopharma, Biotechnology, Medical, Pharmaceutical.
Stage: Series B+.
Based in: Singapore, Singapore.
Total raised: $69M in 2 sourced rounds.
Last round: May 6, 2025 · 559 days ago.
Headcount: 11–50 employees.
On Recent Funding since: Oct 1, 2026.

Signals

Website registeredFeb 3, 2021 (5 years old)
TIMELINE · MONEY RAISED

Nuevocor | 135 days from website to first raise on record

Raised $69M in 2 sourced rounds·1 signal before the first raise
$17M$35M$52M$69MFEBDECOCTAUGJUNAPRFEBDEC$69M||WEBSITE CREATED · FEB 3, 2021$24M Series A · Jun 18, 2021$24M A · JUN '21$45M Series B+ · May 6, 2025$45M B+ · MAY '25

Money raised, round by round (amounts linked to their source). Pins are dated signals; hover the icons for dates.

Funding rounds

DateRoundAmountLeadSource
Series B+$45MAAngelini Venturesfundraisingfox.com
Series A$24MBBoehringer Ingelheim Venture Fundprnewswire.com

Timeline

  1. Website created

Founders and team

Investors

Companies like Nuevocor

Other companies backed by Angelini Ventures

Angelini Ventures portfolio →

Sources and API

Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/nuevocor (get a free API key).

Top raises, every week

The week's top funded startups and market insights, in your inbox every Monday.

Unsubscribe anytime · privacy